FinancingDecoy Therapeutics, IncSalarius Pharmaceuticals, LLCDecoy Therapeutics files S-1 to register 2.37 million resale shares tied to warrant inducementThe shares back warrants issued to Armistice Capital after a September 22 inducement exercise, with the placement closing September 23 and the company flagging going-concern doubt.SEC filing
FinancingDecoy Therapeutics, IncSalarius Pharmaceuticals, LLCDecoy Therapeutics closes $3.85 million warrant inducement transactionThe Houston biotech got holders to exercise Series B milestone warrants at a reduced price and issued new warrants for double the shares in exchange.SEC filing
FinancingDecoy Therapeutics, IncSalarius Pharmaceuticals, LLCDecoy Therapeutics closes $3.85 million warrant inducement transactionThe company induced exercise of Series B warrants at a reduced price and issued new warrants for up to 2,368,868 shares, closing September 23, 2026.SEC filing